Published in J Opt Soc Am A Opt Image Sci Vis on September 01, 1998
Validation of the PowerRefractor for measuring human infant refraction. Optom Vis Sci (2006) 1.00
Peripheral refraction with and without contact lens correction. Optom Vis Sci (2010) 0.88
Inverse optical design of the human eye using likelihood methods and wavefront sensing. Opt Express (2008) 0.87
Higher order monochromatic aberrations of the human infant eye. J Vis (2005) 0.85
Monochromatic aberrations of human eyes in the horizontal visual field. J Opt Soc Am A Opt Image Sci Vis (2002) 0.81
Peripheral aberrations and image quality for contact lens correction. Optom Vis Sci (2011) 0.79
Monochromatic ocular wave aberrations in young monkeys. Vision Res (2006) 0.78
The BHVI-EyeMapper: peripheral refraction and aberration profiles. Optom Vis Sci (2014) 0.77
Evaluation of optical function using a new point spread function analysis system in cataractous and pseudophakic eyes: preliminary results. Jpn J Ophthalmol (2006) 0.76
Optical and neural anisotropy in peripheral vision. J Vis (2016) 0.75
Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes. Infect Immun (1998) 3.92
Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J Bacteriol (1979) 3.40
Visualization of gene expression in living adult Drosophila. Science (1996) 2.92
A two-component regulatory system playing a critical role in plant pathogens and endosymbionts is present in Brucella abortus and controls cell invasion and virulence. Mol Microbiol (1998) 2.60
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments. Infect Immun (1998) 2.55
Controlling the maturation of pathogen-containing vacuoles: a matter of life and death. Nat Cell Biol (1999) 2.17
Biological activities of Brucella abortus lipopolysaccharides. Infect Immun (1981) 2.13
Nucleotide sequence of the 16S rRNA from Brucella abortus. Nucleic Acids Res (1989) 2.05
Immunochemical characterization of Brucella lipopolysaccharides and polysaccharides. Infect Immun (1981) 1.96
The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides. Infect Immun (1995) 1.82
The two-component system BvrR/BvrS essential for Brucella abortus virulence regulates the expression of outer membrane proteins with counterparts in members of the Rhizobiaceae. Proc Natl Acad Sci U S A (2002) 1.77
Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J Clin Microbiol (1992) 1.74
[Validity of the protocol for evaluating the inappropriate use of hospitalization]. Med Clin (Barc) (1996) 1.70
Comparative study of the clinical efficacy of two different coumarin dosages in the management of arm lymphedema after treatment for breast cancer. Lymphology (1999) 1.51
Evaluation of a radial immunodiffusion test with polysaccharide B antigen for diagnosis of bovine brucellosis. J Clin Microbiol (1980) 1.50
Characterization of Brucella abortus and Brucella melitensis native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide. J Bacteriol (1996) 1.49
Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect (2006) 1.49
Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48
Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity. Immunotechnology (1997) 1.48
Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts. J Bacteriol (1996) 1.47
Immunochemical characterization of rough Brucella lipopolysaccharides. Infect Immun (1984) 1.45
A new species of Leishmania parasite from the Venezuelan Andes region. Trans R Soc Trop Med Hyg (1979) 1.43
The immune spectrum in patients with pulmonary tuberculosis. Am Rev Respir Dis (1981) 1.43
Characterization of Brucella abortus soluble antigen employed in immunoassay. J Clin Microbiol (1980) 1.43
[Caroli disease: a case report and review of literature]. Acta Gastroenterol Latinoam (1998) 1.39
[Laparoscopic cholecystectomy without pneumoperitoneum. A review of 150 cases]. Acta Gastroenterol Latinoam (2000) 1.39
Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg (1996) 1.39
Comparative analysis of Brucella serotype A and M and Yersinia enterocolitica O:9 polysaccharides for serological diagnosis of brucellosis in cattle, sheep, and goats. J Clin Microbiol (1993) 1.38
Primary extragastrointestinal stromal tumors in the omentum and mesentery: a clinicopathological and immunohistochemical study. Hepatogastroenterology (2008) 1.38
Half-life of the plasma membrane ATPase and its activating system in resting yeast cells. Biochim Biophys Acta (1991) 1.33
Brucella abortus lipopolysaccharide is mitogenic for spleen cells of endotoxin-resistant C3H/HeJ mice. J Immunol (1979) 1.32
Immunochemical identification of Brucella abortus lipopolysaccharide epitopes. Clin Diagn Lab Immunol (1994) 1.31
GTPases of the Rho subfamily are required for Brucella abortus internalization in nonprofessional phagocytes: direct activation of Cdc42. J Biol Chem (2001) 1.27
Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a down-regulator of T cell activation. J Immunol (2000) 1.24
Enzyme immunoassays for serological diagnosis of bovine brucellosis: A trial in Latin America. Clin Diagn Lab Immunol (1998) 1.23
Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE. Immunology (1980) 1.22
Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils. Infect Immun (1992) 1.20
Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance. Infect Immun (2000) 1.17
Entanglement of two qubits mediated by one-dimensional plasmonic waveguides. Phys Rev Lett (2011) 1.15
Soil pollution by a pyrite mine spill in Spain: evolution in time. Environ Pollut (2004) 1.15
Lysosomal accumulation and recycling of lipopolysaccharide to the cell surface of murine macrophages, an in vitro and in vivo study. J Immunol (1999) 1.12
Brucella lipopolysaccharides and polysaccharides. Ann Inst Pasteur Microbiol (1987) 1.11
Invasion and intracellular trafficking of Brucella abortus in nonphagocytic cells. Microbes Infect (2000) 1.11
Induction of immune and adjuvant immunoglobulin G responses in mice by Brucella lipopolysaccharide. Infect Immun (1984) 1.10
The outer membrane of Brucella ovis shows increased permeability to hydrophobic probes and is more susceptible to cationic peptides than are the outer membranes of mutant rough Brucella abortus strains. Infect Immun (1999) 1.09
[Invasive fungal infections in liver transplant recipients: analysis of 21 cases]. Med Clin (Barc) (1998) 1.07
Modulation of endocytosis in nuclear factor IL-6(-/-) macrophages is responsible for a high susceptibility to intracellular bacterial infection. J Immunol (1999) 1.05
Regulation of Brucella virulence by the two-component system BvrR/BvrS. Vet Microbiol (2002) 1.05
The depth-of-field of the human eye from objective and subjective measurements. Vision Res (1999) 1.05
Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain. Mol Psychiatry (2011) 1.04
Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behav Pharmacol (2005) 1.03
Pollution of soils by the toxic spill of a pyrite mine (Aznalcollar, Spain). Sci Total Environ (1999) 1.02
Heterogeneity of Brucella abortus lipopolysaccharides. Res Microbiol (1995) 1.01
An epidemiological study of epilepsy and epileptic seizures in two rural Guatemalan communities. Ann Trop Med Parasitol (2001) 1.01
Images in cardiology: Right atrial lithomyxoma with extramedullary hematopoiesis. Heart (2002) 1.00
Complete disruption of the main pancreatic duct: endoscopic management. Gastrointest Endosc (1995) 0.99
Histological diagnosis of cytomegalovirus hepatitis in liver allografts. J Clin Pathol (1995) 0.98
Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. Clin Infect Dis (2001) 0.97
Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A2 from Bothrops asper snake venom--synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region. Eur J Biochem (1998) 0.96
Diaphragmatic or transdiaphragmatic thoracic involvement in hepatic hydatid disease: surgical trends and classification. World J Surg (1995) 0.94
Moderate concentrations of ethanol inhibit endocytosis of the yeast maltose transporter. Appl Environ Microbiol (1997) 0.94
BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease. Gene Ther (2010) 0.94
Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. J Infect Dis (1996) 0.94
Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study. Eur Heart J (1997) 0.93
Depletion of monocytes from human peripheral blood leucocytes by passage through sephadex G-10 columns. J Immunol Methods (1978) 0.93
Alterations in the GAL4 DNA-binding domain can affect transcriptional activation independent of DNA binding. J Biol Chem (1998) 0.93
Internal trehalose protects endocytosis from inhibition by ethanol in Saccharomyces cerevisiae. Appl Environ Microbiol (2000) 0.92
Adolescent exposure to nicotine modifies acute functional responses to cannabinoid agonists in rats. Behav Brain Res (2006) 0.91
Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes. Infect Immun (1999) 0.91
Calcitonin and bisphosphonates treatment in bone loss after liver transplantation. Calcif Tissue Int (1995) 0.90
De novo tumors after orthotopic liver transplantation. Transplant Proc (2002) 0.90
Compative study of bladder versus enteric drainage in pancreas transplantation. Transplant Proc (2009) 0.90
Analysis of warm ischemia time for prediction of primary nonfunction of the hepatic graft. Transplant Proc (1991) 0.90
Soil pollution by oxidation of tailings from toxic spill of a pyrite mine. Sci Total Environ (2001) 0.89
Interaction of limestone grains and acidic solutions from the oxidation of pyrite tailings. Environ Pollut (2005) 0.89
Epiphrenic diverticula, esophageal carcinoma and esophagopleural fistula. Hepatogastroenterology (2001) 0.88
Pathology of striped dolphins (Stenella coeruleoalba) infected with Brucella ceti. J Comp Pathol (2009) 0.88
Comparative analysis of the results of orthotopic liver transplantation in patients with and without portal vein thrombosis. Transplant Proc (2005) 0.88
Immunological findings in immunoblastic lymphadenopathy. A detailed case study. Clin Exp Immunol (1977) 0.88
Mechanism of fluoride uptake by hydroxyapatite. Arch Oral Biol (1971) 0.88
Modification of immune response in mice by ciprofloxacin. Antimicrob Agents Chemother (1995) 0.88
Ambient trace element background concentrations in soils and their use in risk assessment. Sci Total Environ (2009) 0.88
Choledochocholedochostomy conversion to hepaticojejunostomy due to biliary obstruction in liver transplantation. World J Surg (2001) 0.87
Intraocular lidocaine in phacoemulsification: an endothelium and blood-aqueous barrier permeability study. Ophthalmology (2000) 0.86
Incidence and predisposing factors for incisional hernia in patients with liver transplantation. Hernia (2001) 0.86
Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications. Leukemia (2011) 0.85
Pharmacological activities of a toxic phospholipase A isolated from the venom of the snake Bothrops asper. Comp Biochem Physiol C (1986) 0.85
Fluoride complexes in drinking water. Arch Oral Biol (1972) 0.85
Catabolite inactivation of the maltose transporter in nitrogen-starved yeast could be due to the stimulation of general protein turnover. FEMS Microbiol Lett (1998) 0.85
Hepatic artery anastomotic stenosis after transplantation: treatment with percutaneous transluminal angioplasty. Radiology (1989) 0.84
When intracellular pathogens invade the frontiers of cell biology and immunology. Histol Histopathol (1997) 0.84
Clathrin and two components of the COPII complex, Sec23p and Sec24p, could be involved in endocytosis of the Saccharomyces cerevisiae maltose transporter. J Bacteriol (1999) 0.84
Liver transplantation and transjugular intrahepatic portosystemic shunt. Transplant Proc (2003) 0.84
Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies. Antimicrob Agents Chemother (1993) 0.84
The low-affinity component of the glucose transport system in Saccharomyces cerevisiae is not due to passive diffusion. Yeast (1995) 0.84
Proximal Femoral Nail Antirotation versus Gamma3 nail for intramedullary nailing of unstable trochanteric fractures. A randomised comparative study. Injury (2012) 0.84
(CCTTT)n polymorphism of NOS2A in nasal polyposis and asthma: a case-control study. J Investig Allergol Clin Immunol (2008) 0.83
Role of the cytoskeleton in endocytosis of the yeast maltose transporter. Yeast (1997) 0.83